TECARTUS dispersion cellulaire sol perf
7680678840011
CH-67884
L01XL06
07.16.4.
1 / 3
google
Details
- Product number
- 6788401
- CPT
- -
- Packaging group
- 1
- Unit
- Beutel
- Composition
- Beutel: brexucaptagenum autoleucelum (Jeder patientenspezifische Einzel-Infusionsbeutel enthält eine Dispersion von Anti-CD19-CAR-T-Zellen in ca. 68 mL für eine Zieldosis von 2x10e6 Anti-CD19-CAR-positiven, lebensfähigen T-Zellen/kg Körpergewicht (Spanne: 1,0x10e6–2,0x10e6 Zellen/kg), mit maximal 2x10e8 Anti-CD19-CAR-positiven, lebensfähigen T-Zellen) 1,0x10e6–2,0x10e6 Zellen/KG/68 ml, CryoStor CS10, natrii chloridi solutio 9 g/L, albuminum humanum (25%), pro praeparatione.
Articles (1)
Tecartus, Infusionsdispersion
Beutel
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
BEU
|
- | Substance | Wirkstoff (Principe actif) |
|
BEU
|
- | Substance | HIMDK |
|
BEU
|
- | Substance | HNIDK |
|
BEU
|
- | Substance | HNIDK |
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 67884
- Drug name
- Tecartus, Infusionsdispersion
- Galenic form
- LSINF
- ATC Code
- L01XL06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/08/2021
- Authorization expiration date
- 24/08/2026
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TECARTUS dispersion cellulaire sol perf
- Description (DE)
- TECARTUS Zelldispersion Inf Lös
- Market launch
- 25/08/2021
- Narcotic (BTM)
- No
Application methods
IV